These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28032401)

  • 1. Targeting human vasohibin-2 by a neutralizing monoclonal antibody for anti-cancer treatment.
    Koyanagi T; Suzuki Y; Komori K; Saga Y; Matsubara S; Fujiwara H; Sato Y
    Cancer Sci; 2017 Mar; 108(3):512-519. PubMed ID: 28032401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
    Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
    Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of rabbit polyclonal antibodies against Vasohibin-2 for determination of its intracellular localization.
    Sun J; Tu M; Han B; Xue X; Zhang Y; Wei J; Chen J; Lu Z; An Y; Cai B; Lv N; Jiang K; Miao Y; Gao W
    Int J Oncol; 2013 Jul; 43(1):255-61. PubMed ID: 23615928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
    Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
    Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo delivery of siRNA targeting vasohibin-2 decreases tumor angiogenesis and suppresses tumor growth in ovarian cancer.
    Koyanagi T; Suzuki Y; Saga Y; Machida S; Takei Y; Fujiwara H; Suzuki M; Sato Y
    Cancer Sci; 2013 Dec; 104(12):1705-10. PubMed ID: 24118388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors.
    Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
    Cancer Sci; 2016 May; 107(5):629-37. PubMed ID: 26893100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma vasohibin-1 and vasohibin-2 are useful biomarkers in patients with esophageal squamous cell carcinoma.
    Yamamoto M; Ozawa S; Ninomiya Y; Koyanagi K; Oguma J; Kazuno A; Hara H; Yatabe K; Kajiwara H; Nakamura N; Sato Y
    Esophagus; 2020 Jul; 17(3):289-297. PubMed ID: 31980976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
    Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
    Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
    Masuda K; Tanabe K; Ujike H; Hinamoto N; Miyake H; Tanimura S; Sugiyama H; Sato Y; Maeshima Y; Wada J
    PLoS One; 2018; 13(4):e0195779. PubMed ID: 29641565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival.
    Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
    Int J Oncol; 2015 Dec; 47(6):2057-63. PubMed ID: 26460696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the vasohibin family in the regulation of fetoplacental vascularization and syncytiotrophoblast formation.
    Suenaga K; Kitahara S; Suzuki Y; Kobayashi M; Horie S; Sugawara J; Yaegashi N; Sato Y
    PLoS One; 2014; 9(9):e104728. PubMed ID: 25184477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vasohibin family: Novel regulators of angiogenesis.
    Sato Y
    Vascul Pharmacol; 2012; 56(5-6):262-6. PubMed ID: 22286022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2.
    Tu M; Lu C; Lv N; Wei J; Lu Z; Xi C; Chen J; Guo F; Jiang K; Li Q; Wu J; Song G; Wang S; Gao W; Miao Y
    Cancer Lett; 2016 Dec; 383(2):272-281. PubMed ID: 27702660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockout of vasohibin-2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer.
    Koyanagi T; Saga Y; Takahashi Y; Tamura K; Yoshiba T; Takahashi S; Taneichi A; Takei Y; Urabe M; Mizukami H; Fujiwara H
    Cancer Med; 2021 Apr; 10(8):2732-2739. PubMed ID: 33710778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of miR-200b/c by inhibiting vasohibin-2 in human retinal microvascular endothelial cells.
    Ding Y; Hu Z; Luan J; Lv X; Yuan D; Xie P; Yuan S; Liu Q
    Life Sci; 2017 Dec; 191():245-252. PubMed ID: 28882646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Novel and Simple Anti-Metastatic Cancer Treatment Targeting Vasohibin-2.
    Lee ES; Suzuki Y; Tomioka H; Nakagami H; Sato Y
    Tohoku J Exp Med; 2023 Nov; 261(3):239-247. PubMed ID: 37704418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasohibin-1 inhibits angiogenesis and suppresses tumor growth in renal cell carcinoma.
    Zhao G; Na R; Li L; Xiao H; Ding N; Sun Y; Han R
    Oncol Rep; 2017 Aug; 38(2):1021-1028. PubMed ID: 28656230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requisite role of vasohibin-2 in spontaneous gastric cancer formation and accumulation of cancer-associated fibroblasts.
    Suzuki Y; Kitahara S; Suematsu T; Oshima M; Sato Y
    Cancer Sci; 2017 Dec; 108(12):2342-2351. PubMed ID: 28960674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity.
    Wentink MQ; Hackeng TM; Tabruyn SP; Puijk WC; Schwamborn K; Altschuh D; Meloen RH; Schuurman T; Griffioen AW; Timmerman P
    Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12532-12537. PubMed ID: 27791128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological Role of Vasohibin in Gastroenterological Cancers: A Meta-Analysis.
    Yamamoto M; Ozawa S; Koyanagi K; Ninomiya Y; Hara H; Kazuno A; Yatabe K; Higuchi T; Nakamura K; Nabeshima K; Sato Y
    Tohoku J Exp Med; 2022 Apr; 256(4):291-301. PubMed ID: 35296570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.